Progyny (PGNY) Depreciation & Amortization (CF) (2018 - 2026)
Progyny's (PGNY) quarterly Depreciation & Amortization (CF) came in at $1.6 million in Q2 2026, up 34.69% year-over-year from $1.2 million in Q2 2025, and up 9.44% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
Progyny (PGNY) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Progyny (PGNY) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 34.69% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $5.7 million, a 42.88% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 55.84% from the prior year.
- Depreciation & Amortization (CF) was $1.6 million for Q2 2026 at Progyny, up from $1.5 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $1.6 million in Q2 2026 and troughed at $364000.0 in Q1 2022.
- A 5-year average of $839500.0 and a median of $735000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) declined 13.74% in 2022 and jumped 59.81% in 2025, its largest moves.
- Over 5 years, Depreciation & Amortization (CF) stood at $446000.0 in 2022, then surged by 42.15% to $634000.0 in 2023, then surged by 36.91% to $868000.0 in 2024, then surged by 57.49% to $1.4 million in 2025, then increased by 18.73% to $1.6 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.6 million (Q2 2026), $1.5 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn | - |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn | 45.53 Mn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn | 19.90 Mn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - | - |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - | 5.78 Mn |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn | 1.62 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn | 415.15 Mn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn | 39.30 Mn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn | 5.94 Mn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn | 1.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 868,000.00 |
| Sep 30, 2024 | 837,000.00 |
| Jun 30, 2024 | 754,000.00 |
| Mar 31, 2024 | 716,000.00 |
| Dec 31, 2023 | 634,000.00 |
| Sep 30, 2023 | 579,000.00 |
| Jun 30, 2023 | 527,000.00 |
| Mar 31, 2023 | 541,000.00 |
| Dec 31, 2022 | 446,000.00 |
| Sep 30, 2022 | 405,000.00 |
| Jun 30, 2022 | 386,000.00 |
| Mar 31, 2022 | 364,000.00 |
| Dec 31, 2021 | 316,000.00 |
| Sep 30, 2021 | 267,000.00 |